30 Day Trial

ORTHOKNOW content is posted to these pages in real time.

Monthly compilations are available in PDF form.

Quarterly Review

3Q14 Revenue: Exactech

$57.9MM, +4% (U.S. $40.0MM, +2%; ex-U.S. $17.9MM, +8%)

  • Hips $10.2MM, +4%
  • Knees $18.1MM, -2%
  • Extremities $18.6MM, +23%
  • Biologics/Spine $5.4MM, -10%
  • Other $5.6MM, -9%


  • Positive early feedback on Alteon flat-wedge tapered stem
  • Knees sluggish in Europe and U.S.
  • Ready to submit Rotating Bearing Knee by mid-4Q
  • Expects to commence U.S. ankle cases in 2H15
  • Pipeline includes shoulder resurfacing, GPS for shoulder, revision knee, line extensions to Logic knee
  • Biologics/Spine affected by substantial pricing pressure in biologics, meaningful price pressure in Europe spine, major spine customer not performing surgery for 1 month